Jpmorgan Chase & CO Vertex Pharmaceuticals Inc Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 6,928,587 shares of VRTX stock, worth $2.75 Billion. This represents 0.26% of its overall portfolio holdings.

Number of Shares

6,928,587

Previous 6,599,785 4.98%

Holding current value

$2.75 Billion

Previous $3.09 Billion 4.17%

% of portfolio

0.26%

Previous 0.27%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$460.0 - $505.78 $151 Million - $166 Million	328,802 Added 4.98%	6,928,587 $3.22 Billion
Q2 2024 Aug 12, 2024	BUY	$392.81 - $485.53 $228 Million - $282 Million	581,661 Added 9.67%	6,599,785 $3.09 Billion
Q1 2024 May 10, 2024	BUY	$407.69 - $446.08 $161 Million - $176 Million	393,859 Added 7.0%	6,018,124 $2.52 Billion
Q4 2023 Feb 12, 2024	SELL	$343.0 - $410.68 $165 Million - $198 Million	-481,587 Reduced 7.89%	5,624,265 $2.29 Billion
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $50.8 Million - $54.5 Million	150,327 Added 2.52%	6,105,852 $2.12 Billion
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $127 Million - $143 Million	-405,233 Reduced 6.37%	5,955,525 $2.1 Billion
Q1 2023 May 18, 2023	BUY	$283.23 - $323.1 $34.3 Million - $39.1 Million	120,990 Added 1.94%	6,360,758 $2 Billion
Q1 2023 May 11, 2023	BUY	$283.23 - $323.1 $212 Million - $242 Million	749,360 Added 13.65%	6,239,768 $1.97 Billion
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $180 Million - $203 Million	630,721 Added 12.98%	5,490,408 $1.59 Billion
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $103 Million - $115 Million	-377,855 Reduced 7.21%	4,859,687 $1.41 Billion
Q2 2022 Aug 11, 2022	BUY	$234.96 - $292.55 $99.8 Million - $124 Million	424,873 Added 8.83%	5,237,542 $1.48 Billion
Q1 2022 May 11, 2022	BUY	$221.42 - $260.97 $77.1 Million - $90.9 Million	348,338 Added 7.8%	4,812,669 $1.26 Billion
Q4 2021 Feb 10, 2022	BUY	$177.01 - $223.45 $44.7 Million - $56.4 Million	252,599 Added 6.0%	4,464,331 $980 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $764 Million - $855 Million	4,211,732 New	4,211,732 $764 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $102B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Vertex Pharmaceuticals Inc Transaction History